Generic drugmaker Viatris has become the first company to ... glargine), meaning that it could be used in place of Sanofi's drug, but only if specifically prescribed for a patient.

In phase studies, the drug was generally well tolerated and reduced disease activity, with the effects more pronounced in more severe cases. Viatris and Idorsia will both provide funding for the ...

"When drug companies put profits over people ... Johnson's (JNJ.N), opens new tab branded fentanyl patch product, Duragesic. Viatris is one of numerous drugmakers accused by state and local ...

Viatris to pay up to $335 million over nine ... a generic injectable version of the life-saving overdose reversal drug, naloxone, as well as a generic buprenorphine/naloxone product used for ...

Viatris (VTRS) announced it has filed applications to the Ministry of Health, Labor and Welfare for approval of Effexor SR Capsules, a ...

Shares of Viatris Inc. VTRS rallied 2.82% to $8.03 Thursday, on what proved to be an all-around favorable trading session for ...

New York, New York-- (Newsfile Corp. - April 26, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Viatris Inc. (NASDAQ: VTRS) and certain ...

Headquartered in Canonsburg, Pennsylvania, Viatris focuses on providing access to a broad range of medicines, including branded, generic, and over-the-counter drugs, as well as complex biologics ...

Viatris Inc. (NASDAQ:VTRS) is a healthcare company that operates in Greater China, Emerging Markets, Developed Markets, and JANZ segments. It provides generic drugs, biosimilars, prescription ...

Such forward-looking statements may include statements regarding the receipt or timing of regulatory approvals; the outcome of clinical trials; the filing of our supplemental New Drug Applications ...

Viatris to Pay up to $335 Million to Resolve ... state and local opioid initiatives as part of the settlement. "When drug companies put profits over people, innocent patients can get sucked ...

Shares of Viatris Inc. VTRS advanced 1.25% to $8.13 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.74% to 5,525.21 and the ...